|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product | |||||
| Licensing and other | |||||
| Total revenues | |||||
| Cost and expenses | |||||
| Cost of revenues | |||||
| Product | |||||
| Licensing and other | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Total cost and expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Interest and other income, net | |||||
| Loss before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net loss | |||||
| Unrealized gain on available-for-sale securities and foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Net loss per share (Note 15): | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average number of shares used in computing basic and diluted net loss per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...